http://www.theheart.org/web_slides/1185967.do
A post hoc analysis of the trial's lipid-lowering arm designed to evaluate the importance of high-sensitivity C-reactive protein (hs-CRP) in measuring CV risk
The document discusses acute and late complications of diabetes mellitus. Acute complications include diabetic ketoacidosis (DKA), insulin shock, and hyperglycemic hyperosmolar nonketotic coma. Late complications involve damage to organs over time and include retinopathy, neuropathy, and nephropathy. Treatment of diabetic nephropathy focuses on blood pressure control using ACE inhibitors or ARBs to slow disease progression.
Presentation on diabetes complications and treatmentHarsh Raghav
Diabetic retinopathy is a complication of diabetes that affects the tiny blood vessels in the retina. High blood glucose levels over a long period of time can damage these blood vessels. Symptoms include blurry or blocked vision that may be accompanied by spots or floaters. The condition progresses through mild, moderate, and severe non-proliferative stages and can become proliferative, potentially causing blindness if left untreated. Risk factors include diabetes, high blood pressure, high cholesterol, and pregnancy.
This document defines and describes the two main types of diabetes - type 1 and type 2. Type 1 results from the body's failure to produce insulin and accounts for 5-10% of cases, often developing in children/young adults. Type 2 is much more common at 90-95% of cases and results from the body becoming resistant to insulin over time. The nursing focus for both types is monitoring blood glucose levels, assessing for complications, and educating patients on lifestyle modifications and medication management.
This document discusses diabetes mellitus, including its types and pathophysiology. It defines diabetes as a chronic metabolic disorder where the body cannot properly metabolize carbohydrates, fats and proteins due to lack of or ineffective insulin. The three main types are type 1, type 2, and gestational diabetes. Complications for both mother and fetus are explained.
This document discusses diabetic ketoacidosis (DKA), providing definitions, symptoms, pathophysiology, diagnosis, treatment, and complications. DKA results from a lack of insulin and causes the body to burn fat and produce acidic ketones. It is defined by hyperglycemia, ketosis, and acidemia. Treatment involves fluid replacement, insulin therapy to lower blood glucose levels, and monitoring for complications like shock, thrombosis, pulmonary edema, and cerebral edema. The goal is to resolve the DKA and transition the patient to their usual insulin regimen and diet to prevent future occurrences.
A literature review examines and evaluates previous research on a topic to establish what is known and unknown. It focuses on scholarly sources and analyzes them using the five C's: cite, compare, contrast, critique, and connect. The review has an introduction outlining the topic and context, a body section examining past research and identifying gaps, and a conclusion summarizing key findings and conclusions. Proper literature reviews are carefully organized, critically analyze sources, and clearly demonstrate how the current research builds upon past work.
acute complication of diabetes mellitus. cardinal biochemical features for DKA. pathophysiology of DKA. clinical assesment of DKA. investigation and management for DKA. complications of DKA.
The document discusses acute complications of diabetes mellitus including hypoglycemia, diabetic ketoacidosis (DKA), and hyperosmolar hyperglycemic state (HHS). It provides details on the pathogenesis, clinical presentation, precipitating factors, diagnostic evaluation, and treatment of DKA and HHS, including fluid resuscitation, insulin therapy, electrolyte replacement, and criteria for resolution prior to transitioning to subcutaneous insulin therapy. Complications of treatment are also discussed.
The document discusses acute and late complications of diabetes mellitus. Acute complications include diabetic ketoacidosis (DKA), insulin shock, and hyperglycemic hyperosmolar nonketotic coma. Late complications involve damage to organs over time and include retinopathy, neuropathy, and nephropathy. Treatment of diabetic nephropathy focuses on blood pressure control using ACE inhibitors or ARBs to slow disease progression.
Presentation on diabetes complications and treatmentHarsh Raghav
Diabetic retinopathy is a complication of diabetes that affects the tiny blood vessels in the retina. High blood glucose levels over a long period of time can damage these blood vessels. Symptoms include blurry or blocked vision that may be accompanied by spots or floaters. The condition progresses through mild, moderate, and severe non-proliferative stages and can become proliferative, potentially causing blindness if left untreated. Risk factors include diabetes, high blood pressure, high cholesterol, and pregnancy.
This document defines and describes the two main types of diabetes - type 1 and type 2. Type 1 results from the body's failure to produce insulin and accounts for 5-10% of cases, often developing in children/young adults. Type 2 is much more common at 90-95% of cases and results from the body becoming resistant to insulin over time. The nursing focus for both types is monitoring blood glucose levels, assessing for complications, and educating patients on lifestyle modifications and medication management.
This document discusses diabetes mellitus, including its types and pathophysiology. It defines diabetes as a chronic metabolic disorder where the body cannot properly metabolize carbohydrates, fats and proteins due to lack of or ineffective insulin. The three main types are type 1, type 2, and gestational diabetes. Complications for both mother and fetus are explained.
This document discusses diabetic ketoacidosis (DKA), providing definitions, symptoms, pathophysiology, diagnosis, treatment, and complications. DKA results from a lack of insulin and causes the body to burn fat and produce acidic ketones. It is defined by hyperglycemia, ketosis, and acidemia. Treatment involves fluid replacement, insulin therapy to lower blood glucose levels, and monitoring for complications like shock, thrombosis, pulmonary edema, and cerebral edema. The goal is to resolve the DKA and transition the patient to their usual insulin regimen and diet to prevent future occurrences.
A literature review examines and evaluates previous research on a topic to establish what is known and unknown. It focuses on scholarly sources and analyzes them using the five C's: cite, compare, contrast, critique, and connect. The review has an introduction outlining the topic and context, a body section examining past research and identifying gaps, and a conclusion summarizing key findings and conclusions. Proper literature reviews are carefully organized, critically analyze sources, and clearly demonstrate how the current research builds upon past work.
acute complication of diabetes mellitus. cardinal biochemical features for DKA. pathophysiology of DKA. clinical assesment of DKA. investigation and management for DKA. complications of DKA.
The document discusses acute complications of diabetes mellitus including hypoglycemia, diabetic ketoacidosis (DKA), and hyperosmolar hyperglycemic state (HHS). It provides details on the pathogenesis, clinical presentation, precipitating factors, diagnostic evaluation, and treatment of DKA and HHS, including fluid resuscitation, insulin therapy, electrolyte replacement, and criteria for resolution prior to transitioning to subcutaneous insulin therapy. Complications of treatment are also discussed.
Diabetic kidney disease, also called diabetic nephropathy, is a type of chronic kidney disease caused by damage to the kidneys as a result of diabetes. Over time, high blood glucose levels associated with diabetes can damage the tiny filters in the kidneys called glomeruli. This can progressively reduce their ability to filter waste from the blood, potentially leading to kidney failure. Symptoms of diabetic kidney disease may include swelling, poor sleep or concentration, nausea or weakness. It can be diagnosed through urine and blood tests and managed through strict control of blood sugar and blood pressure levels.
Chronic complications of diabetes mellitus include microvascular complications that affect the eyes (retinopathy), kidneys (nephropathy), and nerves (neuropathy), as well as macrovascular complications like coronary heart disease and cerebrovascular disease. Both microvascular and macrovascular complications can result in diabetic foot and erectile dysfunction. The mechanisms behind these complications include the formation of advanced glycosylation end products due to high blood glucose, increased activity of the sorbitol pathway, and activation of protein kinase C. Early detection and treatment of these complications can help prevent further damage.
Diabetic retinopathy is a complication of diabetes mellitus where changes occur in the retina. It is a leading cause of vision loss among working age adults in Malaysia. The risk of retinopathy rises with longer duration of diabetes and poor blood glucose control. Annual eye screening is recommended to detect early signs and plan treatment. Laser photocoagulation is commonly used to treat early stages while vitrectomy may be used for advanced proliferative cases with vitreous hemorrhage. Anti-VEGF drugs combined with laser can also treat diabetic macular edema.
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITINJyothi Reshma S
This document discusses the interpretation of several common laboratory tests used in evaluating health conditions, including C-reactive protein (CRP), tumor markers, and serum ferritin.
CRP is an acute phase reactant that is elevated in response to infections, inflammatory disorders, and some malignancies. It is used to evaluate the extent of inflammation and monitor disease activity in conditions like rheumatoid arthritis. Elevated CRP is also associated with increased cardiovascular risk.
Tumor markers are substances often elevated in certain cancers that can help with diagnosis, monitoring treatment response, and detecting recurrence. Examples discussed include AFP for liver and germ cell cancers, CA125 for ovarian cancer, CEA for colorectal cancer,
Chronic complications of diabetes mellitus can affect many organ systems and cause significant morbidity and mortality. These complications can be divided into microvascular complications (like retinopathy, neuropathy, and nephropathy), macrovascular complications (such as coronary artery disease), and nonvascular issues (including gastroparesis and sexual dysfunction). The risk of complications increases with the duration of hyperglycemia. Clinical trials show that maintaining glycemic control through intensive diabetes management can prevent or reduce many of these complications.
This study evaluated C-reactive protein (CRP) levels as an early predictor of major septic complications after elective colorectal surgery. The study found that an insufficient decrease in CRP levels between the 2nd and 5th postoperative days, defined as less than 36%, highly predicted major septic complications with a sensitivity of 90% and negative predictive value of 97%. CRP levels higher than 300mg/L on the 2nd postoperative day indicated early major septic complications. The study concluded that measuring CRP decrease can help identify patients at risk of complications and determine when patients can be safely discharged.
Diabetic nephropathy is the leading cause of end-stage renal disease. About 20-30% of patients with type 1 or type 2 diabetes develop nephropathy, which involves stages of hyperfiltration, microalbuminuria, proteinuria, and finally end-stage renal disease. Risk factors include age, race, ethnicity, history of microalbuminuria, hypertension, poor glycemic control, and smoking. Treatment aims to control blood pressure and block the renin-angiotensin system using ACE inhibitors, angiotensin receptor blockers, or calcium channel blockers to slow the progression of kidney damage.
1. Diabetic peripheral neuropathy (DPN) is damage to nerves caused by high blood sugar levels from diabetes, resulting in pain symptoms.
2. DPN is diagnosed clinically based on symptoms of numbness, tingling, and pain in a glove/stocking distribution, especially in the feet. Sensory testing and nerve conduction studies can support the diagnosis.
3. Screening tools that incorporate both patient interviews about sensory symptoms and physical exams of nerve function have high sensitivity and specificity for diagnosing neuropathic pain compared to tools relying only on interviews.
This document discusses chronic complications of diabetes mellitus, focusing on microvascular complications including retinopathy, nephropathy, neuropathy, and foot disease as well as macrovascular complications affecting the coronary, cerebral, and peripheral circulations. It provides details on the pathogenesis, risk factors, diagnosis, and management of diabetic retinopathy and nephropathy. It also covers diabetic neuropathy, including different types, clinical features, and treatments. The document concludes with a discussion of diabetic foot complications including foot ulcers and Charcot neuroarthropathy.
This document provides information about diabetes and diabetic retinopathy for medical students. It outlines learning objectives related to understanding diabetes demographics, diagnosis, complications, and treatments. Key points include that diabetes affects over 29 million Americans and has significant medical costs. Diabetic retinopathy is a leading cause of blindness and its progression can be slowed by controlling blood sugar and blood pressure. The document also defines the stages of diabetic retinopathy and diabetic macular edema.
A sufficient decrease in C-reactive protein (CRP) levels after elective colorectal surgery can predict an uneventful recovery. The study found that patients who developed early complications had higher CRP levels on the second postoperative day compared to uncomplicated patients. A decrease in CRP levels between the second and fifth postoperative days of less than 36% for open surgery and 48% for laparoscopic surgery indicated a risk of developing late complications. Monitoring CRP levels in the early postoperative period can help identify patients at risk of septic complications and guide safe discharge from the hospital.
This document describes diabetic retinopathy (DR), its classification, pathogenesis, risk factors, screening protocols, and treatment. DR is classified as non-proliferative DR (NPDR) or proliferative DR (PDR). NPDR is further divided into mild, moderate, severe, and very severe stages based on lesions seen. PDR is characterized by new blood vessel growth. Clinically significant macular edema (CSME) can occur and cause vision loss. Screening intervals depend on DR severity. Laser treatment is used for CSME, PDR, and sometimes severe NPDR to prevent vision loss complications like vitreous hemorrhage or retinal detachment. Good glucose and blood pressure control can delay DR progression.
Lecture 1: Hematology introducion For TID and HIV Medicine MSc studentsMulugeta Gobezie
This document provides an overview of basic hematology and hematopoiesis. It defines hematology as the study of blood and discusses the organization of blood and blood forming organs. Key points include: hematopoiesis occurs primarily in the bone marrow and involves the production of red blood cells, white blood cells, and platelets from stem cells; the spleen, liver, lymph nodes and thymus also play roles in blood cell production and filtration; and abnormalities in hematopoiesis can provide early signs of disease.
Suffocation is a general term used to indicate death due to lack of oxygen from either lack of oxygen in the breathable environment or obstruction of external air passages. Asphyxia is caused by lack of oxygen in respired air leading to hypoxaemia and hypercapnia. Smothering causes asphyxia through mechanical obstruction of the external airways (nose and mouth). Suicidal smothering often involves placing a plastic bag over the head in an attempt to cut off oxygen. Classic signs of asphyxia include petechial hemorrhages, cyanosis, congestion, and soft tissue swelling due to increased venous pressure and fluid leakage from blood vessels.
World Vision Pakistan implements several disaster risk reduction and early warning projects in Muzaffargarh, including the Community Resilience Project from 2013-2014. This project aimed to increase community resilience through mainstreaming DRR across development programs, forming disaster management committees in 10 villages, conducting hazard assessments, installing early warning systems, and training volunteers and children. Challenges included limited funding, staffing issues, and the complex security situation. Lessons indicated a need for longer-term strategies, mainstreaming DRR into other sectors, and strengthening coordination between organizations and the government.
Diabetic nephropathy is a chronic kidney disease characterized by gradually increasing urinary albumin excretion, high blood pressure, declining kidney function, and presence of diabetic retinopathy. It develops in 20-40% of people with diabetes and is the leading cause of end-stage renal disease. The pathophysiology involves metabolic and hemodynamic pathways as well as genetic factors. Hyperglycemia causes kidney damage through increased polyol pathway flux, formation of advanced glycation end products, activation of protein kinase C, and other mechanisms. Hemodynamic changes from hypertension increase glomerular pressure and permeability. Genetic factors like ACE polymorphisms also influence risk. Progression is associated with proteinuria, anemia
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...Shahid Nawaz
Nephelometry is commonly used to determine protein levels in body fluids like serum and urine. It works by measuring the light scattered by antigen-antibody complexes formed when a sample containing antigen is mixed with corresponding antiserum. The amount of light scattered is proportional to the antigen concentration in the sample. This document provides instructions for using a nephelometer to test samples for C-reactive protein (CRP) levels, including preparing reagents and standards, running samples, generating a calibration curve from standards, and recording results. CRP levels between 0.0-1.0 mg/dL are considered normal.
The document discusses diabetic retinopathy, including its definition, signs and symptoms, causes, risk factors, stages, treatments including laser photocoagulation and intravitreal injections, and importance of glycemic and blood pressure control. It emphasizes the need for regular eye exams in people with diabetes to screen for and treat diabetic eye diseases early.
This document discusses automation in hematology. It begins by outlining the necessity for automation in cell counting, diagnosing various blood conditions, and performing multiple tests on a single platform. The document then covers the advantages and disadvantages of automation, including increased speed and accuracy versus high costs. It describes the various principles used in automated hematology analyzers, such as electrical impedance, optical light scattering, and flow cytometry. Finally, it provides details on specific analyzers like the Pentra ES 60 and Pentra DF Nexus.
TCT 2012 research highlights: A slideshow presentationtheheart.org
TCT 2012 took place in Miami, FL, on October 22-26. Key trials and presentations at the sessions included: PFO Closure, RESPECT, PC Trial, FAME II, ADVANCE, TAVR, TRILOGY-ACS, Live cases, DESSOLVE I and II, SES PARTNER B, MASTER, Career Achievement Award, ADAPT-DES, STEMI-RADIAL and POST
ESC 2012 research highlights: A slideshow presentationtheheart.org
The European Society of Cardiology (ESC) 2012 Congress took place in Munich, Germany from August 25 through August 29, 2012. Key trials presented at the sessions include: WOEST, ALTITUDE, FAME II, TRILOGY ACS, ACCESS EU,PURE, GARY. IABP SHOCK II, PARAMOUNT and DeFACTO
The American Heart Association (AHA) 2012 Scientific Sessions took place in Los Angeles, CA on November 3-7, 2012. Key trials presented at the sessions include: FREEDOM, TACT, UMPIRE, PHS II, OPERA and FORWARD, ASPIRE, TRILOGY ACS/ARCTIC, MADIT-RIT, RELAX-AHF, POSEIDON / SCIPIO, PCSK9 studies, PCSK9, dal-OUTCOMES andLoDoCo.
Diabetic kidney disease, also called diabetic nephropathy, is a type of chronic kidney disease caused by damage to the kidneys as a result of diabetes. Over time, high blood glucose levels associated with diabetes can damage the tiny filters in the kidneys called glomeruli. This can progressively reduce their ability to filter waste from the blood, potentially leading to kidney failure. Symptoms of diabetic kidney disease may include swelling, poor sleep or concentration, nausea or weakness. It can be diagnosed through urine and blood tests and managed through strict control of blood sugar and blood pressure levels.
Chronic complications of diabetes mellitus include microvascular complications that affect the eyes (retinopathy), kidneys (nephropathy), and nerves (neuropathy), as well as macrovascular complications like coronary heart disease and cerebrovascular disease. Both microvascular and macrovascular complications can result in diabetic foot and erectile dysfunction. The mechanisms behind these complications include the formation of advanced glycosylation end products due to high blood glucose, increased activity of the sorbitol pathway, and activation of protein kinase C. Early detection and treatment of these complications can help prevent further damage.
Diabetic retinopathy is a complication of diabetes mellitus where changes occur in the retina. It is a leading cause of vision loss among working age adults in Malaysia. The risk of retinopathy rises with longer duration of diabetes and poor blood glucose control. Annual eye screening is recommended to detect early signs and plan treatment. Laser photocoagulation is commonly used to treat early stages while vitrectomy may be used for advanced proliferative cases with vitreous hemorrhage. Anti-VEGF drugs combined with laser can also treat diabetic macular edema.
Interpretation of lab tests - CRP, TUMOR MARKERS, SERUM FERRITINJyothi Reshma S
This document discusses the interpretation of several common laboratory tests used in evaluating health conditions, including C-reactive protein (CRP), tumor markers, and serum ferritin.
CRP is an acute phase reactant that is elevated in response to infections, inflammatory disorders, and some malignancies. It is used to evaluate the extent of inflammation and monitor disease activity in conditions like rheumatoid arthritis. Elevated CRP is also associated with increased cardiovascular risk.
Tumor markers are substances often elevated in certain cancers that can help with diagnosis, monitoring treatment response, and detecting recurrence. Examples discussed include AFP for liver and germ cell cancers, CA125 for ovarian cancer, CEA for colorectal cancer,
Chronic complications of diabetes mellitus can affect many organ systems and cause significant morbidity and mortality. These complications can be divided into microvascular complications (like retinopathy, neuropathy, and nephropathy), macrovascular complications (such as coronary artery disease), and nonvascular issues (including gastroparesis and sexual dysfunction). The risk of complications increases with the duration of hyperglycemia. Clinical trials show that maintaining glycemic control through intensive diabetes management can prevent or reduce many of these complications.
This study evaluated C-reactive protein (CRP) levels as an early predictor of major septic complications after elective colorectal surgery. The study found that an insufficient decrease in CRP levels between the 2nd and 5th postoperative days, defined as less than 36%, highly predicted major septic complications with a sensitivity of 90% and negative predictive value of 97%. CRP levels higher than 300mg/L on the 2nd postoperative day indicated early major septic complications. The study concluded that measuring CRP decrease can help identify patients at risk of complications and determine when patients can be safely discharged.
Diabetic nephropathy is the leading cause of end-stage renal disease. About 20-30% of patients with type 1 or type 2 diabetes develop nephropathy, which involves stages of hyperfiltration, microalbuminuria, proteinuria, and finally end-stage renal disease. Risk factors include age, race, ethnicity, history of microalbuminuria, hypertension, poor glycemic control, and smoking. Treatment aims to control blood pressure and block the renin-angiotensin system using ACE inhibitors, angiotensin receptor blockers, or calcium channel blockers to slow the progression of kidney damage.
1. Diabetic peripheral neuropathy (DPN) is damage to nerves caused by high blood sugar levels from diabetes, resulting in pain symptoms.
2. DPN is diagnosed clinically based on symptoms of numbness, tingling, and pain in a glove/stocking distribution, especially in the feet. Sensory testing and nerve conduction studies can support the diagnosis.
3. Screening tools that incorporate both patient interviews about sensory symptoms and physical exams of nerve function have high sensitivity and specificity for diagnosing neuropathic pain compared to tools relying only on interviews.
This document discusses chronic complications of diabetes mellitus, focusing on microvascular complications including retinopathy, nephropathy, neuropathy, and foot disease as well as macrovascular complications affecting the coronary, cerebral, and peripheral circulations. It provides details on the pathogenesis, risk factors, diagnosis, and management of diabetic retinopathy and nephropathy. It also covers diabetic neuropathy, including different types, clinical features, and treatments. The document concludes with a discussion of diabetic foot complications including foot ulcers and Charcot neuroarthropathy.
This document provides information about diabetes and diabetic retinopathy for medical students. It outlines learning objectives related to understanding diabetes demographics, diagnosis, complications, and treatments. Key points include that diabetes affects over 29 million Americans and has significant medical costs. Diabetic retinopathy is a leading cause of blindness and its progression can be slowed by controlling blood sugar and blood pressure. The document also defines the stages of diabetic retinopathy and diabetic macular edema.
A sufficient decrease in C-reactive protein (CRP) levels after elective colorectal surgery can predict an uneventful recovery. The study found that patients who developed early complications had higher CRP levels on the second postoperative day compared to uncomplicated patients. A decrease in CRP levels between the second and fifth postoperative days of less than 36% for open surgery and 48% for laparoscopic surgery indicated a risk of developing late complications. Monitoring CRP levels in the early postoperative period can help identify patients at risk of septic complications and guide safe discharge from the hospital.
This document describes diabetic retinopathy (DR), its classification, pathogenesis, risk factors, screening protocols, and treatment. DR is classified as non-proliferative DR (NPDR) or proliferative DR (PDR). NPDR is further divided into mild, moderate, severe, and very severe stages based on lesions seen. PDR is characterized by new blood vessel growth. Clinically significant macular edema (CSME) can occur and cause vision loss. Screening intervals depend on DR severity. Laser treatment is used for CSME, PDR, and sometimes severe NPDR to prevent vision loss complications like vitreous hemorrhage or retinal detachment. Good glucose and blood pressure control can delay DR progression.
Lecture 1: Hematology introducion For TID and HIV Medicine MSc studentsMulugeta Gobezie
This document provides an overview of basic hematology and hematopoiesis. It defines hematology as the study of blood and discusses the organization of blood and blood forming organs. Key points include: hematopoiesis occurs primarily in the bone marrow and involves the production of red blood cells, white blood cells, and platelets from stem cells; the spleen, liver, lymph nodes and thymus also play roles in blood cell production and filtration; and abnormalities in hematopoiesis can provide early signs of disease.
Suffocation is a general term used to indicate death due to lack of oxygen from either lack of oxygen in the breathable environment or obstruction of external air passages. Asphyxia is caused by lack of oxygen in respired air leading to hypoxaemia and hypercapnia. Smothering causes asphyxia through mechanical obstruction of the external airways (nose and mouth). Suicidal smothering often involves placing a plastic bag over the head in an attempt to cut off oxygen. Classic signs of asphyxia include petechial hemorrhages, cyanosis, congestion, and soft tissue swelling due to increased venous pressure and fluid leakage from blood vessels.
World Vision Pakistan implements several disaster risk reduction and early warning projects in Muzaffargarh, including the Community Resilience Project from 2013-2014. This project aimed to increase community resilience through mainstreaming DRR across development programs, forming disaster management committees in 10 villages, conducting hazard assessments, installing early warning systems, and training volunteers and children. Challenges included limited funding, staffing issues, and the complex security situation. Lessons indicated a need for longer-term strategies, mainstreaming DRR into other sectors, and strengthening coordination between organizations and the government.
Diabetic nephropathy is a chronic kidney disease characterized by gradually increasing urinary albumin excretion, high blood pressure, declining kidney function, and presence of diabetic retinopathy. It develops in 20-40% of people with diabetes and is the leading cause of end-stage renal disease. The pathophysiology involves metabolic and hemodynamic pathways as well as genetic factors. Hyperglycemia causes kidney damage through increased polyol pathway flux, formation of advanced glycation end products, activation of protein kinase C, and other mechanisms. Hemodynamic changes from hypertension increase glomerular pressure and permeability. Genetic factors like ACE polymorphisms also influence risk. Progression is associated with proteinuria, anemia
What is Nephelometry,and a fully automated Nephlometer analyzer for protein a...Shahid Nawaz
Nephelometry is commonly used to determine protein levels in body fluids like serum and urine. It works by measuring the light scattered by antigen-antibody complexes formed when a sample containing antigen is mixed with corresponding antiserum. The amount of light scattered is proportional to the antigen concentration in the sample. This document provides instructions for using a nephelometer to test samples for C-reactive protein (CRP) levels, including preparing reagents and standards, running samples, generating a calibration curve from standards, and recording results. CRP levels between 0.0-1.0 mg/dL are considered normal.
The document discusses diabetic retinopathy, including its definition, signs and symptoms, causes, risk factors, stages, treatments including laser photocoagulation and intravitreal injections, and importance of glycemic and blood pressure control. It emphasizes the need for regular eye exams in people with diabetes to screen for and treat diabetic eye diseases early.
This document discusses automation in hematology. It begins by outlining the necessity for automation in cell counting, diagnosing various blood conditions, and performing multiple tests on a single platform. The document then covers the advantages and disadvantages of automation, including increased speed and accuracy versus high costs. It describes the various principles used in automated hematology analyzers, such as electrical impedance, optical light scattering, and flow cytometry. Finally, it provides details on specific analyzers like the Pentra ES 60 and Pentra DF Nexus.
TCT 2012 research highlights: A slideshow presentationtheheart.org
TCT 2012 took place in Miami, FL, on October 22-26. Key trials and presentations at the sessions included: PFO Closure, RESPECT, PC Trial, FAME II, ADVANCE, TAVR, TRILOGY-ACS, Live cases, DESSOLVE I and II, SES PARTNER B, MASTER, Career Achievement Award, ADAPT-DES, STEMI-RADIAL and POST
ESC 2012 research highlights: A slideshow presentationtheheart.org
The European Society of Cardiology (ESC) 2012 Congress took place in Munich, Germany from August 25 through August 29, 2012. Key trials presented at the sessions include: WOEST, ALTITUDE, FAME II, TRILOGY ACS, ACCESS EU,PURE, GARY. IABP SHOCK II, PARAMOUNT and DeFACTO
The American Heart Association (AHA) 2012 Scientific Sessions took place in Los Angeles, CA on November 3-7, 2012. Key trials presented at the sessions include: FREEDOM, TACT, UMPIRE, PHS II, OPERA and FORWARD, ASPIRE, TRILOGY ACS/ARCTIC, MADIT-RIT, RELAX-AHF, POSEIDON / SCIPIO, PCSK9 studies, PCSK9, dal-OUTCOMES andLoDoCo.
AHA 2010 research highlights: A slideshow presentation theheart.org
http://www.theheart.org/editorial-program/1156073.do
The American Heart Association (AHA) 2010 Scientific Sessions took place in Chicago. Key trials presented at the sessions include: ADVANCE,RAFT,QRS EMPHASIS-HF,ASCEND HF,ROCKET AF,CLOSURE I,GRAVITAS,P-OM3,BASKET-PROVE,DEFINE,SYMPLICITY HTN,ASCOT CRP and ACT.
TCT 2010 research highlights: A slideshow presentation theheart.org
http://www.theheart.org/editorial-program/1128553.do
The 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium took place in Washington. Key trials presented at the meeting include: PARTNER, ZILVER PTX, ISAR-TEST 4,SORT-OUT 4, COMPARE,SPIRIT IV, HORIZONS-AMI, BIOFREEDOM, PROTECT-AF, CAP and Robotically assisted PCI
The CHAMPION trials studied the use of cangrelor, an intravenous antiplatelet drug, in patients undergoing percutaneous coronary intervention (PCI). CHAMPION-PCI found no benefit of cangrelor over clopidogrel in reducing death, myocardial infarction, or ischemia-driven revascularization at 48 hours. CHAMPION-PLATFORM found no difference in the primary outcome but found cangrelor reduced death and stent thrombosis compared to placebo at 48 hours, though it increased major bleeding. The lead investigator acknowledged the definition of periprocedural myocardial infarction may have been too liberal, while another expert questioned some of the conclusions.
ONTARGET trial - Summary & Results with Ramipril Global Endpointtheheart.org
The ONTARGET trial compared the angiotensin receptor blocker (ARB) telmisartan to the angiotensin converting enzyme (ACE) inhibitor ramipril and their combination in 25,620 patients with cardiovascular disease or diabetes. The trial found that telmisartan was noninferior to ramipril for the primary outcome of cardiovascular death, heart attack, stroke or hospitalization for heart failure. The combination of telmisartan and ramipril showed no additional benefit compared to ramipril alone and was associated with more side effects such as renal impairment.
OASIS-6 trial - Summary & Results at ACCtheheart.org
http://www.theheart.org/web_slides/1136801.do
A randomized, placebo study using patients with STEMI exposed to fondaparinux or to usual care-placebo. The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes.
http://www.theheart.org/web_slides/1136565.do
A prospective,randomized, open-label, blinded-end-point evaluation trial on incremental decrease in endpoints through aggressive lipid lowering (IDEAL) using patients with a history of acute MI
http://www.theheart.org/web_slides/1283911.do
A survey of 153,996 adults on prospective urban rural epidemiology (PURE) to examine the relationship of societal influences on human lifestyle behaviors, CV risk factors, and incidence of chronic non communicable diseases
http://www.theheart.org/web_slides/1146197.do
A randomized study,on action to control cardiovascular risk in diabetes and blood-pressure-lowering arm (ACCORD BP) in a nonblinded fashion, to intensive BP-lowering
http://www.theheart.org/web_slides/1186083.do
A randomized study on Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) with patients undergoing an angiographic procedure.
http://www.theheart.org/web_slides/1144191.do
A randomized to prasugrel or clopidogrel study on TRITON-TIMI 38 with patients who have moderate- to high-risk ACS.
http://www.theheart.org/web_slides/1425587.do
A randomized to placebo or ivabradine study on Systolic Heart Failure Treatment with the If Inhibitor Ivabradine (SHIFT) with patients on standard HF medications according to guidelines
http://www.theheart.org/web_slides/1146285.do
A prospective randomized trial on Embolic Protection in Patients with Atrial Fibrillation (PROTECT-AF) comparing closure of the LAA* (with the Watchman occluder) with long-term warfarin therapy
http://www.theheart.org/web_slides/1242353.do
An analysis based on an Italian registry of 308 patients with Brugada syndrome who underwent programmed electrical stimulation (PES) studies according to one consistent protocol (unlike earlier multicenter studies that were based on varying PES protocols)
http://www.theheart.org/web_slides/1242347.do
A trial on ALTITUDE to evaluate mortality after device implantation or after shock therapy in large numbers of patients with implanted devices
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
2. ASCOT-CRP (Anglo-Scandinavian Cardiac
Outcomes Trial—C-Reactive Protein)
PS Sever (Imperial College, London, UK)
American Heart Association 2010 Scientific Sessions
• A post hoc analysis of the trial's lipid-lowering arm designed to evaluate the
importance of high-sensitivity C-reactive protein (hs-CRP) in measuring CV risk
• Included 485 patients:
Who reached the composite end point (CV death, nonfatal MI, coronary
revascularization, or fatal/nonfatal stroke)
Were age- and sex-matched to 1367 patients in the control group who hadn't
suffered one of those events
Were followed for 5.5 years
3. ASCOT-CRP: Results
Measuring hs-CRP had little to no utility in refining CV risk assessment beyond
classic risk factors
• Baseline levels of hs-CRP and LDL-C were significantly correlated with each other
(p<0.0001) and both were predictive of the composite CV end point:
OR 1.31 (95% CI 1.10–1.56; p=0.002) for LDL-C
OR 1.19 (95% CI 1.05–1.34; p=0.006) for every one–standard-deviation increase
in hs-CRP
• Lower on-treatment LDL-C but not hs-CRP was associated with a highly significant
reduction in CV events over six months:
LDL-C <2.1 mmol/L (median) vs LDL-C ≥ 2.1 mmol/L predicted a reduction in the
composite end point (adjusted OR=0.41, 95% CI 0.22–0.75; p=0.004)
hs-CRP <1.83 mg/L (median) vs hs-CRP ≥ 1.83 mg/L showed no such predictive
effect (adjusted OR=0.86, 95% CI 0.49–1.51; p=0.60)
4. ASCOT-CRP: Commentary*
"It is clear that achievement of low LDL-cholesterol levels confers great benefit, and
there's no added benefit by achieving a lower CRP level."
- Dr Peter S Sever
"I'm not as convinced as Dr Sever that this damages the CRP hypothesis."
- Dr Roger Blumenthal
"It's a post hoc analysis of a previously published trial and we must take it with a
grain of salt. It was a particularly high-risk primary-prevention cohort, and it's fair to
say there were a relatively small number of events."
- Dr Donald Lloyd Jones
*All comments from ASCOT analysis fuels debate over JUPITER-based CRP indication for statins
(http://www.theheart.org/article/1153661.do)
5. Become a member of http://www.theheart.org
Become a fan on Facebook: http://www.facebook.com/theheartorg
Follow us on Twitter: http://www.twitter.com/theheartorg
theheart.org is the leading online source of independent cardiology news.
We are the top provider of news and opinions for over 100 000 physicians.